Uveal Melanoma Prognostic Test
Use
Genetic testing of eye tumor tissue to determine whether the original eye tumor has a high risk of metastasis
Special Instructions
This test is performed at Impact Genetics, Bowmanville, Ontario, Canada. Please direct any questions regarding this test to Impact Genetics at 877-624-9769. The test involves a comprehensive genetic and chromosomal analysis to refine prognostic insights for uveal melanoma.
Limitations
This test was developed, and its performance characteristics determined, by Labcorp. It has not been cleared or approved by the Food and Drug Administration. The analysis focuses on genetic mutations and chromosomal alterations common in uveal melanoma. Variability in tumor sampling and DNA quality may affect test results. Moreover, the test does not cover all possible genetic variants or mutations, focusing primarily on those with established clinical relevance in uveal melanoma.
Methodology
Other
Biomarkers
LOINC Codes
- 41103-3
Result Turnaround Time
35-42 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
8.5 mL
Minimum Volume
4 mL
Container
Yellow-top (ACD) tube or lavender-top (EDTA) tube
Collection Instructions
Whole blood samples must be received at Impact Genetics within five days of collection. Do not freeze.
Storage Instructions
Room temperature. Whole blood is stable at room temperature for five days.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |